Gail Nunlee-Bland, MD, Howard University Hospital to speak at conference, May 15-17, in Atlanta, GA

MONROVIA, CA, April 25, 2012 (Press-News.org) Telehealth's positive impact on health outcomes in the treatment of diabetes will be discussed in a presentation by Gail Nunlee-Bland, MD, Director and Chief of Endocrinology, Diabetes Treatment Center, Howard University Hospital at the Diabetes Centers of Excellence Conference.

Part of the Healthcare Centers of Excellence Summit, the Conference is scheduled May 15-17, 2012 at the Meliá Atlanta Hotel. May 15th will be the pre-Summit Workshop, Developing a Sustainable Healthcare Business Model.

Dr. Nunlee-Bland will use a 2008 study conducted at the Howard University Diabetes Treatment Center in conjunction with the Minority Organ Tissue Transplant Education Program as a reference for her highly anticipated presentation. The study compared hemoglobin, blood pressure and body mass index (BMI) changes in low-income African American type 2 diabetes patients. Patients were either randomized to receive diabetes education from a nurse through telemedicine support or received usual care from their primary care provider without telemedicine support. Results of the study revealed significant changes n hemoglobin and BMI measurements in the intervention group.

Healthcare executives attending the Conference will gain important insight into the benefits of telemedicine's applications, benefits and limitations at a diabetes center and determine if their facilities will yield improvements by utilizing this cutting edge treatment technology.

Other speakers in addition to Dr. Nunlee-Bland at the Diabetes Centers of Excellence Conference include:

John L. Brooks III, President and Chief Executive Officer, Joslin Diabetes Center
Diana Bruno, Principal, Una Vita
Manisha Chandalia, MD, Director, Stark Diabetes Center, The University of Texas Medical Branch at Galveston
Gabrielle DeTorra, Principal and Senior Strategic Marketing Consultant, DeTorra Consulting, LLC
Les Jebson, Executive Director, The University of Florida Diabetes Center of Excellence
Robert A. Minkin, MBA, FACHE, Senior Vice President, The Camden Group
Beth Pfeffer, RN, BSN, CDE, Director Diabetes Services, The Nebraska Medical Center
Marian Rewers, MD, Ph.D., Professor of Pediatrics & Medicine, Clinical Director, Barbara Davis Center for Diabetes, University of Colorado School of Medicine
Abby Schwartz, RN BSN MBA, Director of Nursing for Business Development, Mount Sinai Hospital
Linda M. Siminerio, PhD, Executive Director, University of Pittsburgh Diabetes Institute
Ronald L. Vance, JD, Managing Director, Navigant Consulting, Inc.

The conference is part of the Healthcare Centers of Excellence Summit, which includes:
1) Cancer Centers of Excellence Conference
2) Cardiac Centers of Excellence Conference

For more information, please visit http://www.gtcinsight.com
Event Website:
http://www.gtcinsight.com/component/conference/?file=home&cn=Diabetes+Centers+of+Excellence&cid=71

ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, infogtcbio@gtcbio.com